Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JBL vs GSK✓SelectedUSD · GSKJBL vs GSK performance historyLatest closeAs of-2.20%11/13
Stock and ETF performance explorer

JBL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+303.6%
GSK return
+44.4%
Excess return
+259.2%
Maximum drawdown
-38.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%+0.5%-2.7%-2.2%
7D+6.3%+1.1%+5.2%+6.3%
30D-13.5%+6.3%-19.8%-13.9%
3M-31.3%+1.8%-33.1%-31.4%
6M-28.4%+1.7%-30.1%-28.7%
YTD+11.6%+6.5%+5.0%+10.5%
1Y+26.1%+9.5%+16.6%+24.5%
3Y+97.4%+65.3%+32.1%+77.8%
All+303.6%+44.4%+259.2%+254.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling